BE505895A - - Google Patents
Info
- Publication number
- BE505895A BE505895A BE505895DA BE505895A BE 505895 A BE505895 A BE 505895A BE 505895D A BE505895D A BE 505895DA BE 505895 A BE505895 A BE 505895A
- Authority
- BE
- Belgium
- Prior art keywords
- khellin
- phenyl
- chromone
- flavone
- found
- Prior art date
Links
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N flavone Chemical compound O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 239000003085 diluting agent Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000012266 salt solution Substances 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- TXZZTLRVXGOMAB-UHFFFAOYSA-N 2-phenyl-2h-chromene Chemical compound C1=CC2=CC=CC=C2OC1C1=CC=CC=C1 TXZZTLRVXGOMAB-UHFFFAOYSA-N 0.000 claims 1
- SXFPNMRWIWIAGS-UHFFFAOYSA-N Khellin Natural products COC1C2CCOC2C(OC)C3OC(C)CC(=O)C13 SXFPNMRWIWIAGS-UHFFFAOYSA-N 0.000 description 10
- HSMPDPBYAYSOBC-UHFFFAOYSA-N khellin Chemical compound O1C(C)=CC(=O)C2=C1C(OC)=C1OC=CC1=C2OC HSMPDPBYAYSOBC-UHFFFAOYSA-N 0.000 description 10
- 229960002801 khellin Drugs 0.000 description 10
- 230000000694 effects Effects 0.000 description 7
- 150000002212 flavone derivatives Chemical class 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- ABJJEPCCQQOWBG-UHFFFAOYSA-N 2-phenylchromen-4-one Chemical compound O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1.O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 ABJJEPCCQQOWBG-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- CJQJCQCJBRYFJB-UHFFFAOYSA-N 2-(3-aminophenyl)chromen-4-one Chemical compound NC1=CC=CC(C=2OC3=CC=CC=C3C(=O)C=2)=C1 CJQJCQCJBRYFJB-UHFFFAOYSA-N 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 101000611655 Homo sapiens Prolactin regulatory element-binding protein Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 102100040658 Prolactin regulatory element-binding protein Human genes 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000004777 chromones Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 125000005594 diketone group Chemical group 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE505895A true BE505895A (forum.php) |
Family
ID=146306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE505895D BE505895A (forum.php) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE505895A (forum.php) |
-
0
- BE BE505895D patent/BE505895A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7732482B2 (en) | Compound from Antrodia camphorata and the use thereof | |
| EP0593601B1 (fr) | Nouvelles compositions a base de derives de la classe des taxanes | |
| US4358461A (en) | Antiallergic agent | |
| BE895724A (fr) | Nouvelle utilisation therapeutique de la dihydrocyclosporine d | |
| CH642358A5 (fr) | Nouvelles spiro-polycyclo-imidazolidinediones et composition pharmaceutique les contenant. | |
| BE1000573A4 (fr) | Derives de 1-(hydroxystyryl)-5h-2,3-benzodiazepine, procede pour les preparer et compositions pharmaceutiques les contenant. | |
| EP0223674A1 (fr) | Acyl-7 benzoxazinones et leurs dérivés, procédé pour les obtenir et compositions pharmaceutiques les contenant | |
| BE505895A (forum.php) | ||
| JPS6330416A (ja) | 脳循環代謝改善剤 | |
| EP0233105B1 (fr) | Compositions thérapeutiques à base de dérivés de 3-alkoxyflavones et nouveaux dérivés de 3-alkoxyflavones | |
| FR2507477A1 (fr) | Nouveau procede de preparation d'un extrait de feuilles d'olea europea riche en oleuropeine, produits obtenus, application a titre de medicaments et compositions les renfermant | |
| EP1523312A1 (fr) | Elevation du taux d' heme oxygynase avec des derives de la rheine | |
| FR2499572A1 (fr) | Le 3',4',5'-trimethoxybenzoate de 17,18-deshydroapovincaminol et ses sels formes par addition avec des acides, leurs utilisations therapeutiques dans le traitement de maladies associees a une proliferation cellulaire, procedes pour leur preparation et produits intermediaires de leur preparation | |
| EP1097145B1 (fr) | Derives de polyhydroxyalkylpyrazine et leur preparation et medicaments les contenant | |
| EP0628047A1 (fr) | Nouvelle application therapeutique de derives du pyridylpyrrolothiazole carboxamide | |
| MATSUI et al. | Studies on the glucaric acid pathway in the metabolism of D-glucuronic acid in mammals. II. Excretion of D-glucaric acid in urine after administration of several monosaccharides and their derivatives to mammals | |
| CH652924A5 (fr) | Produits pharmaceutique ameliorant le metabolisme des lipides. | |
| EP0027085B1 (fr) | Nouveaux dérivés de la thiazolo (3,2-c) benzoxazine-1,3, leur préparation et les médicaments qui les contiennent | |
| CA2952913C (fr) | Utilisation d'un compose 3-aryl-4-catechol-pyrrole-n-propanol et ses derives pour le traitement du cancer et des pathologies associees a une angiogenese excessive | |
| FR2744121A1 (fr) | Nouveaux derives de 2-chloro-3-arylamino-1-4-naphtoquinone, leur procede de preparation et leur utilisation comme agent pour inhiber l'agregation plaquettaire | |
| BE828694R (fr) | Thieno-benzopyrannes et thiopyrano-benzopyrannes, produits intermediaires et procede pour leur obtention | |
| EP0522944A2 (fr) | Utilisation du (pyridyl-3)-3-1H,3H-pyrrolo 1,2-c thiazole-carboxamide-7 pour le traitement des infections à rétrovirus | |
| FR2499571A1 (fr) | Nouveaux derives d'apovincaminol, leur preparation et leur application en tant que medicaments | |
| BE678902A (forum.php) | ||
| FR2654620A1 (fr) | Nouveaux derives organiques de metal de transition a structure porphyrinique et composition therapeutique le contenant, en particulier activite hypoglycemiante. |